nice tirzepatide obesity Mounjaro is second drug to be approved for use in England | Obesity New Breakthrough Obesity Drug

ifte fayda: Diyabet ve obeziteyi ayn anda hedef alr

Important: These are company-reported topline results

According to Yucca Health's safety information pages, GLP-1 medications like semaglutide and tirzepatide have important contraindications: Do not use if: You or a family member has a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) You have had a severe allergic reaction to semaglutide, tirzepatide, or any ingredients in the formulation You are pregnant, planning to become pregnant, or breastfeeding (GLP-1 medications are not recommended during pregnancy or breastfeeding) Use with caution and close medical supervision if you have: History of pancreatitis or pancreas problems Kidney problems or history of kidney disease Severe gastrointestinal issues such as gastroparesis Type 2 diabetes with history of diabetic retinopathy (semaglutide specifically) Are taking other medications including insulin or sulfonylureas (increased risk of hypoglycemia) The provider reviewing your intake will screen for these factors and may decline to prescribe if contraindications are present or request additional information before making a determination

Find Your Weight Loss Solution at Bliss The decision to lose weight is a deeply personal one, so we hope you can trust our team to guide you through the journey as you choose the best tools for your body